<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We evaluated the methylation patterns of <z:chebi fb="0" ids="15358">histone</z:chebi> H3 lysine 27 (H3K27), H3 lysine 36 (H3K36) and the expression of H3K27 methylase EZH2 in patients with colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> with metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> to search for biomarkers identifying these patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Double 2-mm core tissue microarrays were made from 54 paraffin-embedded samples of primary colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and corresponding <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and examined using an immunohistochemical analysis of dimethylation and trimethylation in H3K27, H3K36 and EZH2 </plain></SENT>
<SENT sid="2" pm="."><plain>Positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell staining for each <z:chebi fb="0" ids="15358">histone</z:chebi> modification (H-score) was used to classify patients into low- and high-staining groups, which were then examined to identify any correlations between the clinicopathological parameters and the clinical outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The H-scores of H3K27me2 were lower in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> than in the corresponding <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e>, while the H-scores of H3K36me2 were higher in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> than in the corresponding <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>H3K27me2 in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (P = 0.016), H3K36me2 in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> correlated with histological type (P = 0.038), and H3K36me3 in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> correlated with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P = 0.017) </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, lower levels of H3K27me2 in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> correlated with poorer survival rates (P = 0.039) </plain></SENT>
<SENT sid="6" pm="."><plain>The multivariate survival analysis showed that the H3K27me2 status is an independent prognostic factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients (P = 0.047) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our findings suggest that the methylation level of H3K27me2 detected with immunohistochemistry may be an independent prognostic factor for metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
</text></document>